FDA moves to kill off homeopathy
Homeopathic Drug Products; Guidance for Food and Drug Administration Staff and Industry; Availability
A Notice by the Food and Drug Administration on 12/07/2022
Document Details
Information about this document as published in the Federal Register.
Printed version:
Publication Date:
Agencies:
Dates:
The announcement of the guidance is published in the Federal Register on December 7, 2022.
Document Type:
Notice
Document Citation:
87 FR 75054
Page:
75054-75055 (2 pages)
Agency/Docket Number:
Docket No. FDA-2017-D-6580
Document Number:
2022-26567
Document Details
Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Document Statistics
Enhanced Content
Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.
Docket Number:
Supporting/Related Materials:
Drug Products Labeled as Homeopathic; Draft Guidance for Food...
Drug Products Labeled as Homeopathic; Draft Guidance for Food...
Request for Extension from Laura Held
Homeopathic Drug Products; Guidance for FDA Staff and Industry
Homeopathic Drug Products; Guidance for Food and Drug...
Request for Extension from Americans for Homeopathy Choice
Drug Products Labeled as Homeopathic Guidance for FDA Staff...
Drug Products Labeled as Homeopathic; Draft Guidance for Food...
Memorandum from American Institute of Homeopathy
Drug Products Labeled as Homeopathic; Draft Guidance for Staff...
See all 15 supporting documents
Enhanced Content
Published Document
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Published Document
Published Document
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice of availability.
SUMMARY:
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for FDA staff and industry entitled “Homeopathic Drug Products.” The guidance describes how FDA intends to prioritize enforcement and regulatory action with regard to drug products, including biological products, labeled as homeopathic and marketed in the United States without the required FDA approval.
DATES:
The announcement of the guidance is published in the Federal Register on December 7, 2022.
For the rest of this article please go to source link below.